- Investing Ideas
- Belgian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Belgian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
3
0 new
Mid-Large Cap Stocks
3 companies
Financière de Tubize
Market Cap: €9.6b
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.
TUB
€219.20
7D
-3.7%
1Y
59.5%
UCB
Market Cap: €47.6b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€250.00
7D
-5.5%
1Y
44.8%
argenx
Market Cap: €49.6b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€796.80
7D
-3.4%
1Y
64.2%